Abstract
1. Autism is a severe neurodevelopmental disorder with potential genetic and environmental etiologies. Recent genetic linkage reports and biochemical analysis of postmortem autistic cerebellum point to Reelin, an important secretory extracellular protein, as being involved in the pathology of autism.
2. We hypothesized that blood levels of Reelin and its isoforms would be altered in autistic twins, and their first degree relatives versus normal controls.
3. We measured blood levels of unprocessed Reelin (410 kDa) and its proteolytic cleavage products (Reelins 330 and 180 kDa) as well as albumin and ceruloplasmin in 28 autistic individuals, their parents (13 fathers, 13 mothers), 6 normal siblings, and 8 normal controls using SDS-PAGE and western blotting.
4. Results indicated significant reductions in 410 kDa Reelin species in autistic twins (−70%, p < 0.01), their fathers (−62%, p < 0.01), their mothers (−72%, p < 0.01), and their phenotypically normal siblings (−70%, p < 0.01) versus controls. Reelin 330 kDa values did not vary significantly from controls. Reelin 180 kDa values for parents (fathers −32% p < 0.05 vs. controls, mothers −34%) declined when compared to controls. In contrast autistic Reelin 180 kDa increased, albeit nonsignificantly versus controls. Albumin and ceruloplasmin values for autistics and their first degree relatives did not vary significantly from controls. There were no significant meaningful correlations between Reelin, albumin and ceruloplasmin levels, age, sex, ADI scores, or age of onset.
5. These results suggest that Reelin 410 deficiency may be a vulnerability factor in the pathology of autism.
Similar content being viewed by others
REFERENCES
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn., American Psychiatric Press, Washington, DC.
Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., Montgomery, M., Rutter, M., and Lantos, P. (1998). A clinicopathological study of autism. Brain 121:889–905.
Bauman, M. L. (1991). Microscopic neuroanatomic abnormalities in autism. Pediatrics 87:791–796.
Berg, D., Weishaupt, A., Francis, M. J., Miura, N., Yang, X. L., Goodyer, I.D., Naumann, M., Koltzenburg, M., Reiners, K., and Becker, G. (2000). Changes of copper-transporting proteins and ceruloplasmin in the centiform nuclei in primary adult-onset dystonia. Ann. Neurol. 47:827–830.
Courchesne, E. (1997). Brainstem, cerebellar, and limbic neuroanatomical abnormalities in autism. Curr. Opin. Neurobiol. 7:269–278.
D'Arcangelo, G., Homayouni, K., Keshvara, L., Rice, D. S., Sheldon, M., and Curran, T. (1999). Reelin is a ligand for lipoprotein receptors. Neuron 24:471–479.
D'Arcangelo, G., Miao, G. G., Chen, S.-C., Soares, H. D., Morgan, J. I., and Curran, T. (1995). A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374:719–723.
D'Arcangelo, G., Nakajima, K., Miyata, T., Ogawa, M., Mikoshiba, K., and Curran, T. (1997). Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J. Neurosci. 17:23–31.
Dulabon, L., Olson, E. C., Taglienti, M.G., Eisenhuth, S., McGrath, B., Walsh, C. A., Kreidberg, J. A., and Anton, E. S. (2000). Reelin binds alpha 3 beta 1 integrin and inhibits neuronal migration. Neuron 27:33–44.
Fatemi, S. H. (2001). Reelin mutations in man and mouse: From reeler mouse to schizophrenia, bipolar disorder, major depression, autism and lissencephaly. Mol. Psychiatry 6:129–133.
Fatemi, S. H., Earle, J. A., and McMenomy, T. (2000). Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry 5:654–663.
Fatemi, S. H., Kroll, J., and Stary, J.M. (2001a). Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. Neuroreport 12:3209–3215.
Fatemi, S. H., Stary, J. M., Halt, A., and Realmuto,G. (2001b). Dysregulation of Reelin and Bcl-2 in autistic cerebellum. J. Autism and Dev. Disord. 31:529–535.
Grant, S. G. N., Karl, K. A., Kiebler, M. A., and Kandel, E. R. (1995). Focal adhesion kinase in the brain: Novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice. Genes Dev. 9:1909–1921.
Guidotti, A., Auta, J., Davis, J., Dwivedi, Y., Grayson, D., Impagnatiello, F., Pandey, G., Pesold, C., Sharma, R., Uzunov,D., Costa, E., and DiGiorgi Gerevini, V. (2000). Decrease in Reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study. Arch. Gen. Psychiatry 57(11):1061–1069.
Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A., and Herz, J. (1999). Direct binding of Reelin to VLDL receptor and ApoE receptor induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24:481–489.
Hong, S. E., Shugart, Y. Y., Huang, D. T., Shahwan, S. A., Grant, P. E., Hourihane, J. O., Martin, N. D., and Walsh, C. A. (2000). Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat. Genet. 26(1):93–96.
Impagnatiello, F., Guidotti, A., Pesold, C., Dwlivedi, Y., Caruncho, H., Pisu, M. G., Uzunov, D. P., Smallheiser, N. R., Davis, J. M., pandey, G. N., Pappas, G. D., Tueting, P., Sharma, R. P., and Costa, E. (1998). A decrease of Reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U.S.A.95:15718–15723.
Kanner L. (1943). Autistic disturbances of affective contact. Nerv. Child. 2:217–250.
Keller, F., Persico, A. M., Zelante, L., Gasperial, P., D'Agruma, N., Maiorano, N., Totaro, A., Militerni, R., Bravaccio, C., Wassink, T. H., Schneider, C., Melmed, R., Trillo, S., Montecchi, F., Palermo, M., Pascucci, T., Puglisi-Allegra, S., Reichelt, K.-L., Conciatori, M., Marino, R., Baldi, A., Quattrocchi, C. C. (2000). Reelin gene alleles and haplotypes are associated with autistic disorder. Society forNeuroscience 26:77(31.11).
Keshvara, L., Benhayon, D., Magdaleno, S., and Curran, T. (2001). Identification of Reelin-induced sitesof tyrosyl phosphorylation on disabled-1. J. Biol. Chem. 276:16008–16014.
Lacor, P., Grayson, D. R., Auta, J., Sugaya, I., Costa, E., and Guidotti, A. (2000). Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. Proc. Natl. Acad. Sci. U.S.A 97:3556–3561.
Lord, C., Rutter, M., and LeCouteur,A. (1994).Autism diagnostic interview-revised:Arevised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J. Autism Dev. Disord. 24:659–685.
Ogawa, M., Miyata, T., Nakajima, K., Yagyu, K., Seike, M., Ikenaka, K., Yamamoto, H., and Mikoshiba, K. (1995). The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial moelcule for laminar organization of cortical neurons. Neuron 14(5):899–912.
Persico, A. M., D'Agruma, L., Maiorano, N., Totaro, A., Militerni, R., Bravaccio, C., Wassink, T. H., Schneider, C., Melmed, R., Trillo, S., Montecchi, F., Palermo, M., Pascucci, T., Puglisi-Allegra, S., Reichelt, K. L., Conciatori, M., Marino, R., Quattrocchi, C. C., Baldi, A., Zelante, L., Gasparini, P., and Keller, F. (2001). Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol. Psychiatry 6(2):150–159.
Quattrocchi, C. C., Wannenes, F., Persico, A. M., Ciafre, S. A., D'Arcangelo, G., Farace, M. G., and Keller, F. (2002). Reelin is a serine protease of the extracellular matrix. J. Biol. Chem. 277(1):303–309.
Robinson, C., Shore, R. C., Bonass, W. A., Brokkes, S. J., Boteva, E., and Kirkham, J. (1998). Identification of human serum albumin in human caries lesions of enamel: The role of putative inhibitors of remineralization. Caries Res. 32:193–199.
Rodier, P. M., Ingram, J. L., Tisdale, B., Nelson, S., and Romano, J. (1996). Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 370:247–261.
Rodriguez, M. A., Pesold, C., Liu, W. S., Kriho, V., Guidotti, A., Pappas, G. D., and Costa, E. (2000). Colocalization of integrin receptors and Reelin in dendritic spine post-synaptic densities of adult non-human primate cortex. Proc. Natl. Acad. Sci. U.S.A 97:3550–3555.
Senzaki, K., Ogawa, M., and Yagi, T. (1999). Proteins of the CNR family are multiple receptors for Reelin. Cell 99:635–647.
Smalheiser, N. R., Costa, E., Guidotti, A., Impagnatiello, F., Auta, J., Lacor, P., Kriho, V., and Pappas, G. D. (2000). Expression of Reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells. Proc. Natl. Acad. Sci. U.S.A 97(3):1281–1286.
Stockinger, W., Brandes, C., Fasching, D., Hermann, M., Gotthardt, M., Herz, J., Schneider, W. J., and Nimpf, J. (2000). The Reelin receptor ApoER2 recruits JNK-interacting proteins-1 &-2. J. Biol. Chem. 275:25625–25632.
Sweet, H. O., Bronson, R. T., Johnson, K. R., Cook, S. A., and Davisson, M. T. (1995). Scrambler, a new neurological mutation of the mouse with abnormalities of neuronal migration. Metam. Genome 7:798–802.
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., and Herz, J. (1999). Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97(6):689–701.
Yoneshima, H., Nagata, E., Matsurgate, M., Yamada, K., Nakajima, K., Miyata, T., Ogawa, M., and Mikoshiba, K. (1997). A novel neurological mutant mouse, yotari, which exhibits reeler-like phenotype but expresses CR-50 antigen-reelin. Neurosci. Res. 29(3):217–223.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fatemi, S.H., Stary, J.M. & Egan, E.A. Reduced Blood Levels of Reelin as a Vulnerability Factor in Pathophysiology of Autistic Disorder. Cell Mol Neurobiol 22, 139–152 (2002). https://doi.org/10.1023/A:1019857620251
Issue Date:
DOI: https://doi.org/10.1023/A:1019857620251